Detalhe da pesquisa
1.
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.
Clin Infect Dis
; 74(8): 1459-1467, 2022 04 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34283213
2.
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
N Engl J Med
; 375(11): 1019-32, 2016 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27626517
3.
Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens.
Liver Int
; 38(5): 821-833, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28941023
4.
Surveillance report of Zika virus among Canadian travellers returning from the Americas.
CMAJ
; 189(9): E334-E340, 2017 Mar 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28280063
5.
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.
J Hepatol
; 64(1): 19-28, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26321288
6.
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial.
Lancet
; 385(9973): 1075-86, 2015 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-25467591
7.
Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection.
Gastroenterology
; 148(2): 355-366.e1, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25311593
8.
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study.
Gut
; 64(6): 948-56, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25080450
9.
Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British Columbia.
Clin Infect Dis
; 60(9): 1368-76, 2015 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25632012
10.
Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis.
JAMA
; 313(17): 1736-44, 2015 May 05.
Artigo
Inglês
| MEDLINE | ID: mdl-25942724
11.
Response to "Selection bias".
CMAJ
; 189(18): E674, 2017 05 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28483851
12.
Daclatasvir and sofosbuvir with ribavirin for 24 weeks in chronic hepatitis C genotype-3-infected patients with cirrhosis: a Phase III study (ALLY-3C).
Antivir Ther
; 24(1): 35-44, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30382942
13.
Spectrum of illness in migrants to Canada: sentinel surveillance through CanTravNet.
J Travel Med
; 26(2)2019 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30395252
14.
Malaria in travellers returning or migrating to Canada: surveillance report from CanTravNet surveillance data, 2004-2014.
CMAJ Open
; 4(3): E352-E358, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27730099
15.
Dermatoses among returned Canadian travellers and immigrants: surveillance report based on CanTravNet data, 2009-2012.
CMAJ Open
; 3(1): E119-26, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25844364
16.
Travel-acquired infections and illnesses in Canadians: surveillance report from CanTravNet surveillance data, 2009-2011.
Open Med
; 8(1): e20-32, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25009682